Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 2
1990 4
1991 2
1992 1
1993 1
1994 3
1995 3
1996 4
1997 3
1998 13
1999 10
2000 8
2001 12
2002 11
2003 12
2004 11
2005 14
2006 13
2007 15
2008 16
2009 32
2010 26
2011 25
2012 30
2013 24
2014 12
2015 11
2016 24
2017 27
2018 19
2019 21
2020 18
2021 15
2022 10
2023 15
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Results by year

Filters applied: . Clear all
Page 1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Among authors: karlsson mo. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Diagnosing model diagnostics.
Karlsson MO, Savic RM. Karlsson MO, et al. Clin Pharmacol Ther. 2007 Jul;82(1):17-20. doi: 10.1038/sj.clpt.6100241. Clin Pharmacol Ther. 2007. PMID: 17571070 Review.
Mechanistic models for myelosuppression.
Friberg LE, Karlsson MO. Friberg LE, et al. Among authors: karlsson mo. Invest New Drugs. 2003 May;21(2):183-94. doi: 10.1023/a:1023573429626. Invest New Drugs. 2003. PMID: 12889739 Review.
An integrated model for the glucose-insulin system.
Silber HE, Jauslin PM, Frey N, Karlsson MO. Silber HE, et al. Among authors: karlsson mo. Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):189-94. doi: 10.1111/j.1742-7843.2009.00510.x. Epub 2009 Dec 29. Basic Clin Pharmacol Toxicol. 2010. PMID: 20050839 Free article. Review.
Pharmacokinetic/pharmacodynamic modelling in oncological drug development.
Karlsson MO, Anehall T, Friberg LE, Henningsson A, Kloft C, Sandström M, Xie R. Karlsson MO, et al. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):206-11. doi: 10.1111/j.1742-7843.2005.pto960310.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733216 Free article. Review.
Open innovation: Towards sharing of data, models and workflows.
Conrado DJ, Karlsson MO, Romero K, Sarr C, Wilkins JJ. Conrado DJ, et al. Among authors: karlsson mo. Eur J Pharm Sci. 2017 Nov 15;109S:S65-S71. doi: 10.1016/j.ejps.2017.06.035. Epub 2017 Jul 4. Eur J Pharm Sci. 2017. PMID: 28684136 Review.
420 results